SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC)
CTIC 9.0900.0%Jun 26 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (933)6/21/2008 2:14:55 AM
From: Icebrg   of 946
 
CTI's meeting goes without a hitch

As I mentioned last week in a story (read it here), some upset Cell Therapeutics stockholders planned to not vote their shares at the company's shareholder meeting out of protest.

Despite the threat, a quorum was reached at Thursday's meeting, which took place without incident.

All of the company's proposals, including a resolution giving the company's board the authority to reverse split the company's stock and a resolution to reduce the quorum necessary to hold future meetings, passed.

During a question and answer period following the meeting, CEO James Bianco said that while the board had the discretion to reverse split the company's shares "it's not something that is definite."

Currently, the company's stock -- which is trading under $1 a share -- is in danger of being delisted from the Nasdaq global market. If it doesn't recover, the shares could be moved to the Nasdaq capital market.

Bianco said that he hoped that the company's stock would recover without a reverse split.

blog.seattlepi.nwsource.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext